🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Grace K. Dy

Roswell Park Comprehensive Cancer Center

ORCID: 0000-0002-5061-0072
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis”.

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002553
N/A
0.637DataRank · unranked
69 citations

Poornima Subramanian, Yan Yatsynovich, David M. Jacobs, Maya R. Chilbert, Umesh C. Sharma +17 more

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.13.095844
N/A
0DataRank · unranked
3 citations

Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood +11 more

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

UNC Libraries(2020)10.17615/74ry-7003
N/A
0DataRank · unranked
0 citations

Editta Baldini, Pierre-Jean Souquet, Grace K. Dy, Ariel López-Chávez, Federico Cappuzzo +25 more

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-21619-0
N/A
0DataRank · unranked
188 citations

Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood +11 more

Using the tumor microenvironment to identify predictors of immunotoxicity to checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2545
N/A
0DataRank · unranked
3 citations

Kristopher Attwood, Kayla Catalfamo, Grace K. Dy, Saby George, Marc S. Ernstoff +2 more

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Archives of cardiovascular diseases(2022)10.1016/j.acvd.2022.03.003
N/A
0DataRank · unranked
40 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani +61 more

Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis

ACS Nano(2023)10.1021/acsnano.2c10970
N/A
0DataRank · unranked
82 citations

Yunchen Yang, Eric Kannisto, Xie Zeng, Yu Guan, Santosh K. Patnaik +5 more

Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0383
N/A
0DataRank · unranked
20 citations

Mark D. Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen +7 more

Exosomal Thomsen–Friedenreich Glycoantigen: A New Liquid Biopsy Biomarker for Lung and Breast Cancer Diagnoses

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0505
N/A
0DataRank · unranked
10 citations

Yafei Su, Kate Rittenhouse‐Olson, Kristopher Attwood, Wilfrido Mojica, Mary E. Reid +3 more

Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.17.613509
N/A
0DataRank · unranked
2 citations

Anthony Rojas, Rebecca G. Zitnay, Keith R. Carney, Wakeiyo Hettinga, Mary C. Schaelling +18 more

Vitamin D3 Metabolites Demonstrate Prognostic Value in EGFR-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance

Cancers(2020)10.3390/cancers12030675
N/A
0DataRank · unranked
20 citations

Grace K. Dy, Sebastiano Battaglia, Alan D. Hutson, Letian Zhang, Yunkai Zhang +6 more

Pulmonary Suffusion Refinements for Primary and Secondary Malignancies: Preliminary Analyses of Phase I Safety and Drug Delivery Data

Cancers(2025)10.3390/cancers17172880
N/A
0DataRank · unranked
0 citations

Sawsan Abdel‐Hady, Garin Tomaszewski, Michael Petroziello, Omar Hasan, Mark Hennon +7 more